Moderna claims it does not have the inventory to deliver the vaccine to India this year. But. There are rumors that the Johnson & Johnson company is likely to export its vaccines from the US to other countries in the future.
The second wave of Kovid has created a huge trench between supply and demand for medicine and vaccines. Thus, two rounds of high-level meetings were chaired by the Cabinet Secretary last week to discuss vaccine availability in global and domestic markets. It was expressed at the meeting that there is now an urgent need to collect vaccines.
'There are not enough vaccines near Moderna to share with India. It plans to release its single dose vaccine to the Indian market in 2022. Moderna is in talks with Cipla and other Indian companies for this, ”the meeting was informed.
US giant pharmaceutical company Pfizer has come forward with a vaccine of 5 crore 1 crore in July, 1 crore in August, 2 crore in September and 1 crore in October. However, it wants to deal directly with the Government of India. It is said that the central government has to pay for Pfizer India.
Currently, the country is offering two 'Made-in-India' vaccines to people. India launched the vaccine campaign in mid-January, making it the largest vaccine campaign in the world. 20 million doses have been given to people in this campaign so far. The third vaccine, approved by the Russian-made Sputnik-V government, is being used on a smaller scale.